These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

803 related items for PubMed ID: 15910558

  • 1. Nine patients with anti-neutrophil cytoplasmic antibody-positive vasculitis successfully treated with rituximab.
    Eriksson P.
    J Intern Med; 2005 Jun; 257(6):540-8. PubMed ID: 15910558
    [Abstract] [Full Text] [Related]

  • 2. Long-term observation of patients with anti-neutrophil cytoplasmic antibody-associated vasculitis treated with rituximab.
    Stasi R, Stipa E, Del Poeta G, Amadori S, Newland AC, Provan D.
    Rheumatology (Oxford); 2006 Nov; 45(11):1432-6. PubMed ID: 16632482
    [Abstract] [Full Text] [Related]

  • 3. Rituximab in relapsing or refractory ANCA-associated vasculitis: a case series of 16 patients.
    Wendt M, Gunnarsson I, Bratt J, Bruchfeld A.
    Scand J Rheumatol; 2012 Mar; 41(2):116-9. PubMed ID: 22118245
    [Abstract] [Full Text] [Related]

  • 4. Effects of anti-CD20 monoclonal antibody as a rescue treatment for ANCA-associated idiopathic systemic vasculitis with or without overt renal involvement.
    Roccatello D, Baldovino S, Alpa M, Rossi D, Napoli F, Naretto C, Cavallo R, Giachino O.
    Clin Exp Rheumatol; 2008 Mar; 26(3 Suppl 49):S67-71. PubMed ID: 18799057
    [Abstract] [Full Text] [Related]

  • 5. [Treatment of ANCA-associated vascularitides].
    Guillevin L, Pagnoux C.
    Presse Med; 2007 May; 36(5 Pt 2):922-7. PubMed ID: 17408912
    [Abstract] [Full Text] [Related]

  • 6. Treatment of refractory retrobulbar granuloma with rituximab in a patient with ANCA-negative Wegener's granulomatosis: a case report.
    Ooka S, Maeda A, Ito H, Omata M, Yamada H, Ozaki S.
    Mod Rheumatol; 2009 May; 19(1):80-3. PubMed ID: 18806927
    [Abstract] [Full Text] [Related]

  • 7. B-cell depletion with rituximab for refractory head and neck Wegener's granulomatosis: a cohort study.
    Martinez Del Pero M, Chaudhry A, Jones RB, Sivasothy P, Jani P, Jayne D.
    Clin Otolaryngol; 2009 Aug; 34(4):328-35. PubMed ID: 19673980
    [Abstract] [Full Text] [Related]

  • 8. Rituximab in refractory ophthalmic Wegener's granulomatosis: PR3 titers may predict relapse, but repeat treatment can be effective.
    Joshi L, Lightman SL, Salama AD, Shirodkar AL, Pusey CD, Taylor SR.
    Ophthalmology; 2011 Dec; 118(12):2498-503. PubMed ID: 21907416
    [Abstract] [Full Text] [Related]

  • 9. Induction of remission by B lymphocyte depletion in eleven patients with refractory antineutrophil cytoplasmic antibody-associated vasculitis.
    Keogh KA, Wylam ME, Stone JH, Specks U.
    Arthritis Rheum; 2005 Jan; 52(1):262-8. PubMed ID: 15641078
    [Abstract] [Full Text] [Related]

  • 10. Rituximab for remission induction in elderly patients with ANCA-associated vasculitis.
    Timlin H, Lee SM, Manno RL, Seo P, Geetha D.
    Semin Arthritis Rheum; 2015 Aug; 45(1):67-9. PubMed ID: 25796088
    [Abstract] [Full Text] [Related]

  • 11. Rituximab versus cyclophosphamide for ANCA-associated vasculitis with renal involvement.
    Geetha D, Specks U, Stone JH, Merkel PA, Seo P, Spiera R, Langford CA, Hoffman GS, Kallenberg CG, St Clair EW, Fessler BJ, Ding L, Tchao NK, Ikle D, Jepson B, Brunetta P, Fervenza FC, Rituximab for ANCA-Associated Vasculitis Immune Tolerance Network Research Group.
    J Am Soc Nephrol; 2015 Apr; 26(4):976-85. PubMed ID: 25381429
    [Abstract] [Full Text] [Related]

  • 12. Treatment of severe renal disease in ANCA positive and negative small vessel vasculitis with rituximab.
    Shah S, Hruskova Z, Segelmark M, Morgan MD, Hogan J, Lee SK, Dale J, Harper L, Tesar V, Jayne DR, Geetha D.
    Am J Nephrol; 2015 Apr; 41(4-5):296-301. PubMed ID: 26044574
    [Abstract] [Full Text] [Related]

  • 13. Myeloperoxidase-Antineutrophil Cytoplasmic Antibody (ANCA)-Positive Granulomatosis With Polyangiitis (Wegener's) Is a Clinically Distinct Subset of ANCA-Associated Vasculitis: A Retrospective Analysis of 315 Patients From a German Vasculitis Referral Center.
    Schirmer JH, Wright MN, Herrmann K, Laudien M, Nölle B, Reinhold-Keller E, Bremer JP, Moosig F, Holle JU.
    Arthritis Rheumatol; 2016 Dec; 68(12):2953-2963. PubMed ID: 27333332
    [Abstract] [Full Text] [Related]

  • 14. [ANCA(antineutrophil cytoplasmic antibodies)-associated vasculitis in a man with extreme fatigue, fever and progressive renal dysfunction].
    Bakashvili N, Swaak AJ, Tervaert JW, Dees A.
    Ned Tijdschr Geneeskd; 2008 Apr 26; 152(17):1009-14. PubMed ID: 18549177
    [Abstract] [Full Text] [Related]

  • 15. ANCA-associated vasculitis: diagnostic and therapeutic strategy.
    Ozaki S.
    Allergol Int; 2007 Jun 26; 56(2):87-96. PubMed ID: 17460438
    [Abstract] [Full Text] [Related]

  • 16. Rituximab versus azathioprine for maintenance in ANCA-associated vasculitis.
    Guillevin L, Pagnoux C, Karras A, Khouatra C, Aumaître O, Cohen P, Maurier F, Decaux O, Ninet J, Gobert P, Quémeneur T, Blanchard-Delaunay C, Godmer P, Puéchal X, Carron PL, Hatron PY, Limal N, Hamidou M, Ducret M, Daugas E, Papo T, Bonnotte B, Mahr A, Ravaud P, Mouthon L, French Vasculitis Study Group.
    N Engl J Med; 2014 Nov 06; 371(19):1771-80. PubMed ID: 25372085
    [Abstract] [Full Text] [Related]

  • 17. Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis: 2-year results of a randomised trial.
    Jones RB, Furuta S, Tervaert JW, Hauser T, Luqmani R, Morgan MD, Peh CA, Savage CO, Segelmark M, Tesar V, van Paassen P, Walsh M, Westman K, Jayne DR, European Vasculitis Society (EUVAS).
    Ann Rheum Dis; 2015 Jun 06; 74(6):1178-82. PubMed ID: 25739829
    [Abstract] [Full Text] [Related]

  • 18. Rituximab for treatment-resistant extensive Wegener's granulomatosis--additive effects of a maintenance treatment with leflunomide.
    Henes JC, Fritz J, Koch S, Klein R, Horger M, Risler T, Kanz L, Koetter I.
    Clin Rheumatol; 2007 Oct 06; 26(10):1711-5. PubMed ID: 17502992
    [Abstract] [Full Text] [Related]

  • 19. S3. Rituximab for ANCA-associated vasculitides: the French experience.
    Charles P, Guillevin L.
    Presse Med; 2013 Apr 06; 42(4 Pt 2):534-6. PubMed ID: 23453207
    [No Abstract] [Full Text] [Related]

  • 20. [Vasculitis management: discovery of antineutrophil cytoplasmic antibodies (ANCA)].
    Guillevin L.
    Presse Med; 2007 May 06; 36(5 Pt 2):843-4. PubMed ID: 17449373
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 41.